Glaukos Corporation
GKOS
Clasificación en acciones
#2017
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Precio por acción
$174.46
Capitalización bursátil
$10.29B
Cambio (1 día)
4.60%
Cambio (1 año)
119.53%
País
US
Comercio Glaukos Corporation (GKOS)
Categoría
Healthcare
Número de acciones en circulación de Glaukos Corporation (GKOS)
Número de acciones en circulación al June 2026: 58.42M
Según los últimos informes financieros y el precio de las acciones de Glaukos Corporation, el número actual de acciones en circulación es 58.42M. Al final de December 2023, la empresa tenía 48.43M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Glaukos Corporation (GKOS) desde 2012 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 58.42M | 10.74% |
| 2024 | 52.76M | 8.92% |
| 2023 | 48.43M | 2.08% |
| 2022 | 47.44M | 2.20% |
| 2021 | 46.42M | 4.33% |
| 2020 | 44.50M | 19.12% |
| 2019 | 37.36M | 6.72% |
| 2018 | 35.00M | 1.81% |
| 2017 | 34.38M | 4.41% |
| 2016 | 32.93M | 88.44% |
| 2015 | 17.47M | -29.78% |
| 2014 | 24.89M | 0.00% |
| 2013 | 24.89M | 1,153.02% |
| 2012 | 1.99M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 1.74B | 2,883.70% |
US
|
|
| 1.28B | 2,094.66% |
IE
|
|
| 383.50M | 556.46% |
US
|
|
| 1.48B | 2,429.31% |
US
|
|
| - | - |
DE
|
